Epidemiology and diagnosis of myopic choroidal neovascularization in Asia

Eye and Contact Lens

Volumn 42, Issue 1, 2016, Pages 48-55

  Chan, Nicole Shu Wen ^a   Teo, Kelvin ^b   Cheung, Chui Ming Gemmy ^b,c,d  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b SINGAPORE NATIONAL EYE CENTRE   (Singapore)

^c SINGAPORE EYE RESEARCH INSTITUTE   (Singapore)

^d DUKE NUS MEDICAL SCHOOL   (Singapore)

Author keywords

Myopic choroidal neovascularization; Myopic maculopathy; Pathologic myopia

Indexed keywords

VASCULOTROPIN; VASCULOTROPIN INHIBITOR; VASCULOTROPIN A;

ASIA; CLINICAL FEATURE; DIFFERENTIAL DIAGNOSIS; FLUORESCENCE ANGIOGRAPHY; HUMAN; LOW VISION; MACULAR DEGENERATION; MYOPIA; MYOPIC CHOROIDAL NEOVASCULARIZATION; OPTICAL COHERENCE TOMOGRAPHY; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; REVIEW; RISK ASSESSMENT; RISK FACTOR; SOCIOECONOMICS; SUBRETINAL NEOVASCULARIZATION; VISUAL IMPAIRMENT; ANTAGONISTS AND INHIBITORS; ASIAN CONTINENTAL ANCESTRY GROUP; CHOROIDAL NEOVASCULARIZATION; COMPLICATION; MYOPIA, DEGENERATIVE; PATHOLOGY; VISION DISORDERS; VISUAL ACUITY;

ASIAN CONTINENTAL ANCESTRY GROUP; CHOROIDAL NEOVASCULARIZATION; DIAGNOSIS, DIFFERENTIAL; HUMANS; MYOPIA, DEGENERATIVE; PROGNOSIS; RISK FACTORS; TOMOGRAPHY, OPTICAL COHERENCE; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VISION DISORDERS; VISUAL ACUITY;

EID: 84952631233     PISSN: 15422321     EISSN: 1542233X     Source Type: Journal    
DOI: 10.1097/ICL.0000000000000201     Document Type: Review

References (101)

1. Morgan IG, Ohno-Matsui K, Saw SM. Myopia. Lancet 2012;379: 1739-1748.
2. Resnikoff S, Pascolini D, Mariotti SP, et al. Global magnitude of visual impairment caused by uncorrected refractive errors in 2004. Bull World Health Organ 2008;86:63-70.
3. Wong TY, Foster PJ, Hee J, et al. Prevalence and risk factors for refractive errors in adult Chinese in Singapore. Invest Ophthalmol Vis Sci 2000;41: 2486-2494.
4. Neelam K, Cheung CM, Ohno-Matsui K, et al. Choroidal neovascularisation in pathological myopia. Prog Retin Eye Res 2012;31:495-525.
5. Morgan I, Rose K. How genetic is school myopia? Prog Retin Eye Res 2005;24:1-38.
6. Pan CW, Ramamurthy D, Saw SM. Worldwide prevalence and risk factors for myopia. Ophthalmic Physiol Opt 2012;32:3-16.
7. Lin LL, Shih YF, Hsiao CK, et al. Prevalence of myopia in Taiwanese schoolchildren: 1983 to 2000. Ann Acad Med Singapore 2004;33:27-33.
8. Wu HM, Seet B, Yap EP, et al. Does education explain ethnic differences in myopia prevalence? A population-based study of young adult males in Singapore. Optom Vis Sci 2001;78:234-239.
9. He M, Zeng J, Liu Y, et al. Refractive error and visual impairment in urban children in southern china. Invest Ophthalmol Vis Sci 2004;45:793-799.
10. Cheng CY, Hsu WM, Liu JH, et al. Refractive errors in an elderly Chinese population in Taiwan: The Shihpai Eye Study. Invest Ophthalmol Vis Sci 2003;44:4630-4638.
11. He M, Huang W, Li Y, et al. Refractive error and biometry in older Chinese adults: The Liwan eye study. Invest Ophthalmol Vis Sci 2009; 50:5130-5136.
12. Lee KE, Klein BE, Klein R, et al. Changes in refraction over 10 years in an adult population: The Beaver Dam Eye study. Invest Ophthalmol Vis Sci 2002;43:2566-2571.
13. Saw SM, Gazzard G, Shih-Yen EC, et al. Myopia and associated pathological complications. Ophthalmic Physiol Opt 2005;25:381-391.
14. Wong TY, Ferreira A, Hughes R, et al. Epidemiology and disease burden of pathologic myopia and myopic choroidal neovascularization: An evidence-based systematic review. Am J Ophthalmol 2014;127:9-25.e12.
15. Duke-Elder S, Abrams D. Pathological refractive errors. In: Duke-Elder S, ed. Systems of Ophthalmology, Volume 5. St Louis, MO, CV Mosby, 1970, pp 297-374.
16. Fredrick DR. Myopia. BMJ 2002;324:1195-1199.
17. Miller DG, Singerman LJ. Natural history of choroidal neovascularisation in high myopia. Curr Opin Ophthalmol 2001;12:222-224.
18. Tokoro T. On the definition of pathologic myopia in group studies. Acta Ophthalmol Suppl 1988;185:107-108.
19. Gao LQ, Liu W, Liang YB, et al. Prevalence and characteristics of myopic retinopathy in a rural Chinese adult population: The Handan Eye Study. Arch Ophthalmol 2011;129:1199-1204.
20. Liu HH, Xu L, Wang YX, et al. Prevalence and progression of myopic retinopathy in Chinese adults: The Beijing Eye Study. Ophthalmology 2010;117:1763-1768.
21. Vongphanit J, Mitchell P, Wang JJ. Prevalence and progression of myopic retinopathy in an older population. Ophthalmology 2002;109:704-711.
22. Cedrone C, Nucci C, Scuderi G, et al. Prevalence of blindness and low vision in an Italian population: A comparison with other European studies. Eye 2006;20:661-667.
23. Klaver CC, Wolfs RC, Vingerling JR, et al. Age-specific prevalence and causes of blindness and visual impairment in an older population: The Rotterdam Study. Arch Ophthalmol 1998;116:653-658.
24. Cotter SA, Varma R, Ying-Lai M, et al; Los Angeles Latino Eye Study Group. Causes of low vision and blindness in adult Latinos: The Los Angeles Latino Eye Study. Ophthalmology 2006;113:1574-1582.
25. Iwase A, Araie M, Tomidokoro A, et al. Prevalence and causes of low vision and blindness in a Japanese adult population: The Tajimi Study. Ophthalmology 2006;113:1354-1362.
26. Xu L, Wang Y, Li Y, et al. Causes of blindness and visual impairment in urban and rural areas in Beijing: The Beijing Eye Study. Ophthalmology 2006;113:1134.e1-1134.e11.
27. Yamada M, Hiratsuka Y, Roberts CB, et al. Prevalence of visual impairment in the adult Japanese population by cause and severity and future projections. Ophthalmic Epidemiol 2010;17:50-57.
28. Hsu WM, Cheng CY, Liu JH, et al. Prevalence and causes of visual impairment in an elderly Chinese population in Taiwan: The Shihpai Eye Study. Ophthalmology 2004;111:62-69.
29. Moriyama M, Ohno-Matsui K, Hayashi K, et al. Topographic analyses of shape of eyes with pathologic myopia by high-resolution three-dimensional magnetic resonance imaging. Ophthalmology 2011;118:1626-1637.
30. Ohno-Matsui K, Shimada N, Yasuzumi K, et al. Long-term development of significant visual field defects in highly myopic eyes. Am J Ophthalmol 2011;152:256-265.e1.
31. Samarawickrama C, Mitchell P, Tong L, et al. Myopia-related optic disc and retinal changes in adolescent children from Singapore. Ophthalmology 2011;118:2050-2057.
32. Chang L, Pan CW, Ohno-Matsui K, et al. Myopia-related fundus changes in Singapore adults with high myopia. Am J Ophthalmol 2013;155:991-999.e1.
33. Pan CW, Cheng CY, Saw SM, et al. Myopia and age-related cataract: A systematic review and meta-analysis. Am J Ophthalmol 2013;156: 1021-1033.e1.
34. Marcus MW, de Vries MM, Junoy Montolio FG, et al. Myopia as a risk factor for open-angle glaucoma: A systematic review and meta-analysis. Ophthalmology 2011;118:1989-1994.e2.
35. Ohno-Matsui K, Akiba M, Moriyama M, et al. Acquired optic nerve and peripapillary pits in pathologic myopia. Ophthalmology 2012;119:1685-1692.
36. Spaide RF, Akiba M, Ohno-Matsui K. Evaluation of peripapillary intrachoroidal cavitation with swept source and enhanced depth imaging optical coherence tomography. Retina 2012;32:1037-1044.
37. Green WR, Wilson DJ. Choroidal neovascularization. Ophthalmology 1986;93:1169-1176.
38. Cohen SY, Laroche A, Leguen Y, et al. Etiology of choroidal neovascularization in young patients. Ophthalmology 1996;103:1241-1244.
39. Curtin BJ, Karlin DB. Axial length measurements and fundus changes of the myopic eye. Am J Ophthalmol 1971;71:42-53.
40. Curtin BJ, Karlin DB. Axial length measurements and fundus changes of the myopic eye. I. The posterior fundus. Trans Am Ophthalmol Soc 1970; 68:312-334.
41. Grossniklaus HE, Green WR. Pathologic findings in pathologic myopia. Retina 1992;12:127-133.
42. Hayashi K, Ohno-Matsui K, Shimada N, et al. Long-term pattern of progression of myopic maculopathy: A natural history study. Ophthalmology 2010;117:1595-1611, 1611.e1-4.
43. Hotchkiss ML, Fine SL. Pathologic myopia and choroidal neovascularization. Am J Ophthalmol 1981;91:177-183.
44. Avila MP, Weiter JJ, Jalkh AE, et al. Natural history of choroidal neovascularization in degenerative myopia. Ophthalmology 1984;91:1573-1581.
45. Bottoni F, Tilanus M. The natural history of juxtafoveal and subfoveal choroidal neovascularization in high myopia. Int Ophthalmol 2001;24:249-255.
46. Yoshida T, Ohno-Matsui K, Yasuzumi K, et al. Myopic choroidal neovascularization: A 10-year follow-up. Ophthalmology 2003;110:1297-1305.
47. Hayashi K, Ohno-Matsui K, Yoshida T, et al. Characteristics of patients with a favorable natural course of myopic choroidal neovascularization. Graefes Arch Clin Exp Ophthalmol 2005;243:13-19.
48. Kojima A, Ohno-Matsui K, Teramukai S, et al. Estimation of visual outcome without treatment in patients with subfoveal choroidal neovascularization in pathologic myopia. Graefes Arch Clin Exp Ophthalmol 2006;244:1474-1479.
49. Kobayashi K, Mandai M, Suzuma I, et al. Expression of estrogen receptor in the choroidal neovascular membranes in highly myopic eyes. Retina 2002;22:418-422.
50. Hampton GR, Kohen D, Bird AC. Visual prognosis of disciform degeneration in myopia. Ophthalmology 1983;90:923-926.
51. Matusumaru H, Hirai H. Prevalence of myopia and refractive changes in students from 3 to 17 years of age. Surv Ophthalmol 1999;44: S109-S115.
52. Pan CW, Wong TY, Lavanya R, et al. Prevalence and risk factors for refractive errors in Indians: The Singapore Indian Eye Study (SINDI). Invest Ophthalmol Vis Sci 2011;52:3166-3173.
53. Saw SM, Chan YH, Wong WL, et al. Prevalence and risk factors for refractive errors in the Singapore Malay Eye Survey. Ophthalmology 2008;115:1713-1719.
54. Seet B, Wong TY, Tan DT, et al. Myopia in Singapore: Taking a public health approach. Br J Ophthalmol 2011;85:521-526.
55. Tong JP, Chan WM, Liu DT, et al. Aqueous humor levels of vascular endothelial growth factor and pigment epithelium-derived factor in polypoidal choroidal vasculopathy and choroidal neovascularization. Am J Ophthalmol 2006;141:456-462.
56. Okamoto N, Tobe T, Hackett SF, et al. Transgenic mice with increased expression of vascular endothelial growth factor in the retina: A new model of intraretinal and subretinal neovascularization. Am J Pathol 1997;151:281-291.
57. Chan WM, Lai TY, Chan KP, et al. Changes in aqueous vascular endothelial growth factor and pigment epithelial derived factor levels following intravitreal bevacizumab injections for choroidal neovascularization secondary to age-related macular degeneration or pathologic myopia. Retina 2008;28:1308-1313.
58. Fujiwara T, Imamura Y, Margolis R, et al. Enhanced depth imaging optical coherence tomography of the choroid in highly myopic eyes. Am J Ophthalmol 2009;148:445-450.
59. Shiose S, Hata Y, Noda Y, et al. Fibrinogen stimulates in vitro angiogenesis by choroidal endothelial cells via autocrine VEGF. Graefes Arch Clin Exp Ophthalmol 2004;242:777-783.
60. Ohno-Matsui K, Yoshida T, Futagami S, et al. Patchy atrophy and lacquer cracks predispose to the development of choroidal neovascularization in pathological myopia. Br J Ophthalmol 2003;87:570-573.
61. Ikuno Y, Jo Y, Hamasaki T, et al. Ocular risk factors for choroidal neovascularization in pathologic myopia. Invest Ophthalmol Vis Sci 2010;51: 3721-3725.
62. Ikuno Y, Sayanagi K, Soga K, et al. Lacquer crack formation and choroidal neovascularization in pathologic myopia. Retina 2008;28:1124-1131.
63. Cheung CM, Loh BK, Li X, et al. Choroidal thickness and risk characteristics of eyes with myopic choroidal neovascularization. Acta Ophthalmol 2013;91:e580-581.
64. Secrétan M, Kuhn D, Soubrane G, et al. Long-term visual outcome of choroidal neovascularization in pathologic myopia: Natural history and laser treatment. Eur J Ophthalmol 1997;7:307-316.
65. Avetisov ES, Savitskaya NF. Some features of the ocular microcirculation in myopia. Ann Ophthalmol 1977;9:1261-1264.
66. Wakabayashi T, Ikuno Y. Choroidal filling delay in choroidal neovascularisation due to pathological myopia. Br J Ophthalmol 2010;94:611-615.
67. Gass JDM. Stereoscopic Atlas of Macular Diseases: Diagnosis and Treatment. St. Louis, CV Mosby, 1997.
68. Harman AM, Hoskins R, Beazley LD. Experimental eye enlargement in mature animals changes the retinal pigment epithelium. Vis Neurosci 1999; 16:619-628.
69. Yoshida A, Ishiko S, Kojima M. Inward and outward permeability of the blood-retinal barrier in experimental myopia. Graefes Arch Clin Exp Ophthalmol 1996;234:S239-S242.
70. Miller H, Miller B, Ryan SJ. The role of retinal pigment epithelium in the involution of subretinal neovascularisation. Invest Ophthalmol Vis Sci 1986;27:1644-1652.
71. Asakuma T, Yasuda M, Ninomiya T, et al. Prevalence and risk factors for myopic retinopathy in a Japanese population: The Hisayama Study. Ophthalmology 2012;119:1760-1765.
72. Curtin BJ. Ocular findings and complications. In: Curtin BJ, ed. The Myopias. Philadelphia, PA, Harper and Row, 1985, pp 277-347.
73. Tokoro T. Types of fundus changes in the posterior pole. In: Tokoro T, ed. Atlas of Posterior Fundus Changes in Pathologic Myopia. Tokyo, Japan, Springer-Verlag, 1998:5-22.
74. Moriyama M, Ohno-Matsui K, Futagami S, et al. Morphology and longterm changes of choroidal vascular structure in highly myopic eyes with and without posterior staphyloma. Ophthalmology 2007;114:1755-1762.
75. Ohno-Matsui K, Kawasaki R, Jonas JB, et al. International photographic classification and grading system for myopic maculopathy. Am J Ophthalmol 2015;159:877-883.e7.
76. Fercher AF, Hitzenberger CK, Drexler W, et al. In vivo optical coherence tomography. Am J Ophthalmol 1993;116:113-114.
77. Huang D, Swanson EA, Lin CP, et al. Optical coherence tomography. Science 1991;254:1178-1181.
78. Hee MR, Izatt JA, Swanson EA, et al. Optical coherence tomography of the human retina. Arch Ophthalmol 1995;113:325-332.
79. Puliafito CA, Hee MR, Lin CP, et al. Imaging of macular diseases with optical coherence tomography. Ophthalmology 1995;102:217-229.
80. Hee MR, Baumal CR, Puliafito CA, et al. Optical coherence tomography of age-related macular degeneration and choroidal neovascularization. Ophthalmology 1996;103:1260-1270.
81. Garcia-Layana A, Salinas-Alaman A, Maldonado MJ, et al. Optical coherence tomography to monitor photodynamic therapy in pathological myopia. Br J Ophthalmol 2006;90:555-558.
82. Baba T, Ohno-Matsui K, Yoshida T, et al. Optical coherence tomography of choroidal neovascularization in high myopia. Acta Ophthalmol Scand 2002;80:82-87.
83. Levy JH, Pollock HM, Curtin BJ. The Fuchs' spot: An ophthalmic and fluorescein angiographic study. Ann Ophthalmol 1977;9:1433-1443.
84. Ohno H. Electron microscopic studies of myopic retinochoroidal atrophies 1. Choroidal changes [in Japanese]. Folia Ophthalmol Jpn 1983;43: 1244-1253.
85. Matsuo N, Okabe S, Hasegawa E, et al. Report of the Research Committee on Chorioretinal Degeneration [In Japanese]. Tokyo, Japan, The Ministry of Health and Welfare of Japan, 1978.
86. Penas SC, Carneiro A, Martinho R, et al. Optical coherence tomography in myopic choroidal neovascularization treated with photodynamic therapy. Invest Ophthalmol Vis Sci 2004;45:3167-3167.
87. Verteporfin in Photodynamic Therapy Study Group. Photodynamic therapy of subfoveal choroidal neovascularization in pathologic myopia with verteporfin. 1-year results of a randomized clinical trial-VIP report no. 1. Ophthalmology 2001;108:841-852.
88. Axer-Siegel R, Cotlear D, Priel E, et al. Indocyanine green angiography in high myopia. Ophthalmic Surg Lasers Imaging 2004;35:139-145.
89. Essex RW, Wong J, Fraser-Bell S, et al. Punctate inner choroidopathy: Clinical features and outcomes. Arch Ophthalmol 2010;128:982-987.
90. Watzke RC, Packer AJ, Folk JC, et al. Punctate inner choroidopathy. Am J Ophthalmol 1984;98:572-584.
91. American Academy of Ophthalmology, The Eye M.D. Association: Focal and Diffuse Choroidal and Retinal Inflammation; in Basic and Clinical Science Course, Section 12: Retina and Vitreous. Leo, 2011-2012.
92. Channa R, Ibrahim M, Sepah Y, et al. Characterization of macular lesions in punctate inner choroidopathy with spectral domain optical coherence tomography. J Ophthalmic Inflamm Infect 2012;2:113-120.
93. Zarranz-Ventura J, Sim DA, Keane PA, et al. Characterization of punctate inner choroidopathy using enhanced depth imaging optical coherence tomography. Ophthalmology 2014;121:1790-1797.
94. Tabandeh H, Flynn HW Jr, Scott IU, et al. Visual acuity outcomes of patients 50 years of age and older with high myopia and untreated choroidal neovascularization. Ophthalmology 1999;106:2063-2067.
95. Yoshida T, Ohno-Matsui K, Ohtake Y, et al. Long-term visual prognosis of choroidal neovascularization in high myopia: A comparison between age groups. Ophthalmology 2002;109:712-719.
96. Fried M, Siebert A, Meyer-Schwickerath G, et al. Natural history of Fuchs' spot: A long-term follow-up study. Doc Ophthal Proc Ser 1981;28:215-222.
97. Hayashi K, Hayashi H. Intravitreal versus retrobulbar injections of triamcinolone for macular edema associated with branch retinal vein occlusion. Am J Ophthalmol 2005;139:972-982.
98. Spaide RF. Age-related choroidal atrophy. Am J Ophthalmol 2009;147: 801-810.
99. Kojima A, Ohno-Matsui K, Teramukai S, et al. Factors associated with the development of chorioretinal atrophy around choroidal neovascularization in pathologic myopia. Graefes Arch Clin Exp Ophthalmol 2004;242:114-119.
100. Wolf S, Balciuniene VJ, Laganovska G, et al. RADIANCE: A randomized controlled study of ranibizumab in patients with choroidal neovascularization secondary to pathologic myopia. Ophthalmology 2014;121:689-692.e2.
101. Ikuno Y, Ohno-Matsui K, Wong TY, et al. Intravitreal aflibercept Injection in patients with myopic choroidal neovascularization: The MYRROR study. Ophthalmology 2015;122:1220-1227.